KAMADA » ALPHA1

‪LEARN ABOUT ALPHA-1‬‬

Alpha-1 Antitrypsin Deficiency ("AATD" or "Alpha-1 deficiency") is a genetic condition which can cause serious liver disease in children and liver and/or lung disease in adults. The most common clinical presentation of Alpha-1 Deficiency is lung disease. That is the reason it is also called "Inherited Emphysema" or "Genetic COPD".

Alpha-1 antitrypsin deficiency is one of the most common genetic disorders worldwide, and its prevalence varies by population. This disorder affects about 1 in 1,500 to 3,500 individuals in European countries and in the US.



 
 

Read more

TESTING FOR ALPHA-1

Testing for AAT deficiency is as easy as a simple finger-stick blood test.
Patients should talk with their physicians about testing if they have risk factors or symptoms that are typical to Alpha-1 deficiency, or if a family member has been diagnosed with Alpha-1 deficiency.
 

Read more

ALPHA-1 IN KAMADA

Kamada’s flagship product is Glassia®; The first and only ready-to-use, FDA approved intravenous Alpha-1 Antitrypsin (AAT), for the treatment of AAT Deficiency.
Kamada's inhaled AAT product, is already in advanced stages of clinical development.

Read more